Cardax Inc Sustainability Reports
Cardax, Inc. is a life sciences enterprise that develops and commercializes dietary supplements and pharmaceuticals targeted at inflammatory health and chronic diseases. Its primary consumer product is ZanthoSyn, a high-absorption astaxanthin dietary supplement.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300KNOOMIHC4WAA25
1 reports from 2019 to 2019
Company Profile
Cardax, Inc. is a life sciences enterprise that develops and commercializes dietary supplements and pharmaceuticals targeted at inflammatory health and chronic diseases. Its primary consumer product is ZanthoSyn, a high-absorption astaxanthin dietary supplement.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
